+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
ID07795528

Observational Study of Molecular Residual Disease Using Circulating Tumor DNA in Stage I-III Colon Adenocarcinoma with Driver Mutations

Led by Ruijin Hospital · Updated on 2026-09-02

392

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of circulating tumor DNA ctDNA testing to monitor molecular residual disease MRD in patients with stage I-III colon adenocarcinoma who have specific driver mutations KRAS, NRAS, BRAF, or PIK3CA and have undergone surgery to remove their tumors. This observational study aims to understand how MRD status after surgery relates to the risk of cancer recurrence and survival outcomes. The study fills a gap by focusing on patients with these genetic mutations and following them closely over time. Participants will have blood samples taken at set times before and after surgery, including several points during a three-year follow-up period. These samples will be tested using a specialized 10-gene sequencing panel to detect tumor DNA fragments in the blood, which may indicate residual cancer. No experimental treatments are given all patients receive standard care and monitoring according to clinical guidelines. During the study, participants will undergo regular physical exams, blood tests for tumor markers, CT scans every six months, and colonoscopies at specified intervals up to three years after surgery. Researchers will analyze how ctDNA results correspond with cancer recurrence and overall survival. The study includes careful tracking of changes in MRD over time and their relationship with outcomes after any additional chemotherapy. The total follow-up lasts three years post-surgery.

CONDITIONS

Brief Title

Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma

Research Team

R

Ren Zhao, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here